Literature DB >> 25933809

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial.

Côme Lepage1, Jean-Marc Phelip2, Laurent Cany3, Roger Faroux4, Sylvain Manfredi5, Jean-Francois Ain6, Denis Pezet7, Mathieu Baconnier8, Philippe Deguiral9, Eric Terrebone10, Antoine Adenis11, Karine Le Malicot12, Laurent Bedenne13, Olivier Bouché14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25933809     DOI： 10.1016/j.dld.2015.03.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  10 in total

1.  Recommendations for follow-up of colorectal cancer survivors.

Authors:  R Vera; J Aparicio; F Carballo; M Esteva; E González-Flores; J Santianes; F Santolaya; J M Fernández-Cebrián
Journal:  Clin Transl Oncol       Date:  2019-02-14       Impact factor: 3.405

Review 2.  Comprehensive literature review of randomized clinical trials examining novel treatment advances in patients with colon cancer.

Authors:  William Paul Skelton; Aaron J Franke; Atif Iqbal; Thomas J George
Journal:  J Gastrointest Oncol       Date:  2020-08

3.  Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Charles J Kahi; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas J Robertson; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-02-12       Impact factor: 10.864

4.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  Mark Jeffery; Brigid E Hickey; Phillip N Hider
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

5.  Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.

Authors:  Xiaobing Wang; Zhaogang Yang; Haimei Tian; Yanfen Li; Mo Li; Wenya Zhao; Chao Zhang; Teng Wang; Jing Liu; Aili Zhang; Di Shen; Cuining Zheng; Jun Qi; Dan Zhao; Junfeng Shi; Liliang Jin; Jianyu Rao; Wei Zhang
Journal:  Oncotarget       Date:  2017-04-11

Review 6.  ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm.

Authors:  Mahendra Naidoo; Peter Gibbs; Jeanne Tie
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

Review 7.  Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC).

Authors:  Sakti Chakrabarti; Anup Kumar Kasi; Aparna R Parikh; Amit Mahipal
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

Review 8.  Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies.

Authors:  Patrick Kirchweger; Helwig Valentin Wundsam; Holger Rumpold
Journal:  World J Clin Oncol       Date:  2022-06-24

9.  Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.

Authors:  Beverley L Høeg; Pernille E Bidstrup; Randi V Karlsen; Anne Sofie Friberg; Vanna Albieri; Susanne O Dalton; Lena Saltbæk; Klaus Kaae Andersen; Trine Allerslev Horsboel; Christoffer Johansen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-21

10.  Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study.

Authors:  Hung-Yu Huang; Min-Wei Lu; Mei-Chi Chen; Hsiu-Mei Chang; Chih-Hsi Kuo; Shu-Min Lin; Chun-Hua Wang; Fu-Tsai Chung
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.